Browsing "1. Journal Papers" by Author : 1429

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 60 of 63

This table browses all dspace content
Issue DateTitleJournal Title
2016A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasisRADIOTHERAPY AND ONCOLOGY
2015A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2023Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer CANCER MEDICINE
2004Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpointsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2022Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer RADIATION ONCOLOGY
2016Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction AnalysisDISEASES OF THE COLON & RECTUM
2009CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2014Can a Biomarker-Based Scoring System Predict Pathologic Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer?DISEASES OF THE COLON & RECTUM
2013Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience RADIATION ONCOLOGY JOURNAL
2016Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fasciaJAPANESE JOURNAL OF CLINICAL ONCOLOGY
2013Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma JOURNAL OF RADIATION RESEARCH
2020Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy CANCER RESEARCH AND TREATMENT
2004Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysisHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2007Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal typeINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer ONCOTARGET
2016Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy ONCOTARGET
2013Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineationRADIOTHERAPY AND ONCOLOGY
2019Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients Frontiers in Oncology
2016Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancersBRITISH JOURNAL OF CANCER
2018Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma. YONSEI MEDICAL JOURNAL
2021Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer RADIATION ONCOLOGY
2015Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume? PLOS ONE
2022First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanomaJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
2012High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2023Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal CancerANNALS OF SURGERY
2015Incorporation of radiotherapy in the multidisciplinary treatment of isolated retroperitoneal lymph node recurrence from colorectal cancerANNALS OF SURGICAL ONCOLOGY
2017Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancerCLINICAL & TRANSLATIONAL ONCOLOGY
2010Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas?INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2023Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach JOURNAL OF GASTRIC CANCER
2017Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancerBRITISH JOURNAL OF SURGERY
2019Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimizationJapanese Journal of Clinical Oncology
2018Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspectiveJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2022Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal CancerCLINICAL COLORECTAL CANCER
2012Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2016MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection PLOS ONE
2015Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer WORLD JOURNAL OF GASTROENTEROLOGY
2020Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer CHINESE JOURNAL OF CANCER RESEARCH
2012Nutritional status of patients treated with radiotherapy as determined by subjective global assessment RADIATION ONCOLOGY JOURNAL
2018Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea CANCER RESEARCH AND TREATMENT
2021Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View YONSEI MEDICAL JOURNAL
2012Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapyRADIOTHERAPY AND ONCOLOGY
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerRADIOTHERAPY AND ONCOLOGY
2014Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkersJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators FRONTIERS IN ONCOLOGY
2017Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon CancerANNALS OF SURGICAL ONCOLOGY
2018Prognostic significance of preoperative CT findings in patients with advanced gastric cancer who underwent curative gastrectomy PLOS ONE
2016Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy considerationJOURNAL OF SURGICAL ONCOLOGY
2017Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer JOURNAL OF RADIATION RESEARCH
2017Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery BMC CANCER
2021Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis FRONTIERS IN ONCOLOGY
2011Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2023Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer YONSEI MEDICAL JOURNAL
2004Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix - A Potential Predictor of Poor Survival CLINICAL CANCER RESEARCH
2018T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancerEUROPEAN RADIOLOGY
2010The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study RADIATION ONCOLOGY
2018The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer.JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2012The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.LIVER INTERNATIONAL
2019Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection Frontiers in Oncology
2021Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastasesEJSO
2020Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial TRIALS
12

Browse

Links